Bioptik Technology Inc 4161
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- TWD 35.25
- Day Range
- TWD 32.75–35.25
- 52-Week Range
- TWD 26.95–41.48
- Bid/Ask
- TWD 33.75 / TWD 34.05
- Market Cap
- TWD 1.80 Bil
- Volume/Avg
- 128,064 / 220,437
Key Statistics
- Price/Earnings (Normalized)
- 21.40
- Price/Sales
- 2.15
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Bioptik Technology Inc is a Taiwan-based company engaged in the research, development, production, and sale of medical devices and reagents. The company is also focused on developing skin care products and aims to engage in developing bioenergy, Astaxanthin, and Cellulose Bioethanol. It is involved in the business areas of Home care medical devices, Skincare- Its own brand, Dietary supplement OEM and ODM, Skincare- OEM and ODM, and Biodiesel. In the Home care business area, the company provides Easy Touch blood glucose monitoring, and blood cholesterol and uric acid monitoring systems, as well as its strips.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 131
- Website
- http://www.bioptik.com.tw
Comparables
Valuation
|
Metric
|
4161
|
4728
|
4142
|
|---|---|---|---|
Price/Earnings (Normalized) | 21.40 | 20.08 | 1,731.89 |
Price/Book Value | 2.25 | 8.71 | 2.19 |
Price/Sales | 2.15 | 7.36 | 6.72 |
Price/Cash Flow | 14.50 | 17.36 | — |
Price/Earnings
4161
4728
4142
Financial Strength
|
Metric
|
4161
|
4728
|
4142
|
|---|---|---|---|
Quick Ratio | 1.22 | 2.12 | 2.12 |
Current Ratio | 1.69 | 2.36 | 2.63 |
Interest Coverage | 9.71 | 305.62 | −22.58 |
Quick Ratio
4161
4728
4142
Profitability
|
Metric
|
4161
|
4728
|
4142
|
|---|---|---|---|
Return on Assets (Normalized) | 5.55% | 30.67% | −3.83% |
Return on Equity (Normalized) | 10.77% | 47.83% | −6.10% |
Return on Invested Capital (Normalized) | 6.07% | 43.03% | −3.83% |
Return on Assets
4161
4728
4142
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Dpddxtyf | Jvnpyh | $182.7 Bil | |
SYK
| Stryker Corp | Czsthwmdtd | Lyk | $124.6 Bil | |
MDT
| Medtronic PLC | Xjryhzvwb | Hzhlz | $105.2 Bil | |
BSX
| Boston Scientific Corp | Nphrzkhm | Vjthvqb | $99.1 Bil | |
EW
| Edwards Lifesciences Corp | Wtyprfhbvw | Wszgsg | $52.0 Bil | |
DXCM
| DexCom Inc | Pjmgjvsd | Rkt | $51.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Qdmbstspd | Mnrr | $24.5 Bil | |
ALGN
| Align Technology Inc | Dvlfdbs | Ccrybm | $22.7 Bil | |
PHG
| Koninklijke Philips NV ADR | Fpvqgnblk | Wtdrnk | $18.3 Bil | |
PODD
| Insulet Corp | Xpkmykth | Vkschv | $11.6 Bil |